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In order to explore the effect of electroacupuncture (EA) for chronic bowel and bladder dysfunction after traumatic spinal cord
injury, 14 patients were treated with electroacupuncture once a day, five times a week for the first four weeks, and once every other
day, three times a week for the following four weeks. The patients were then followed up for six months. After treatment, four
(4/14, 28.57%) patients resumed normal voiding; six (6/14, 42.86%) resumed normal voiding for no less than half of all micturition
behaviors; four (4/14, 28.57%) required supplementary urination methods for higher than half of all micturition behaviors. These
effects persisted during followup. Mean postvoid RUV decreased by 190.29 ± 101.87mL (𝑃 < 0.01) after treatment and by
198.86±112.18mL (𝑃 < 0.01) during followup. Patients’ weekly urinary incontinence frequency decreased 7.14±46.34 times/week
(𝑃 = 0.036) after treatment and decreased 49.86 ± 44.38 times/week during followup. After treatment, four (4/14, 28.57%) patients
resumed normal bowel movements (𝑃 = 0.025); five (5/14, 35.71%) reduced the dependence on supplementary defecationmethods;
five (5/14, 35.71%) had no changes. In patients with chronic bowel and bladder dysfunction after traumatic SCI, EA may provide a
valuable alternative tool in improving patients’ self-controlled bowel and bladder functions with minimal side effects.
1. Introduction
Traumatic spinal cord injury (SCI) is an accidental disaster,
causing unexpected suffering physically, emotionally, and
costly to patients [1]. Traumatic SCI can cause disorders
of somatesthesia and locomotion below the level of injury.
Neurogenic bladder and bowel dysfunctions which affect the
physical and psychological health of patients and severely
decrease the quality of life are also prevalent in patients with
traumatic SCI. Urological complications of neurogenic blad-
der caused by traumatic SCI consist of inability to empty the
bladder, urinary tract infections (UTIs), incontinence, and
upper urinary tract deterioration [2]. A distended bladder
may also cause pressure effects on adjacent structures includ-
ing the left common iliac vein in the pelvis leading to adverse
events of other organs [3]. Common bowel dysfunctions
in patients with SCI may include poorly localized abdom-
inal pain, difficulty with bowel evacuation, hemorrhoids,
abdominal distention, and autonomic hyperreflexia arising
from the gastrointestinal tract [4]. In patients with SCI,
treatments for bladder dysfunctionsmay involve conservative
treatments (drug treatments, catheterization, assisted bladder
emptying, rehabilitation, and external appliances), minimally
invasive treatments (botulinum toxin A injections in bladder,
intravesical vanilloid treatment, sphincterotomy, and ureteral
reimplantation), and surgical treatments (autoaugmentation,
sacral anterior root stimulation, sacral neuromodulation, and
artificial urinary sphincter) [5]; treatments for bowel dys-
functions may include nonpharmacological therapies (sup-
positories, reflex stimulation, abdominal massage, assistive
devices, and others), pharmacological agents (prucalopride,
metoclopramide, neostigmine, and others), and surgical
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interventions (implantation of electrical stimulation systems,
colostomy, antegrade continence enema, and enema conti-
nence catheter) [6]. Although these treatments are effective to
some extent, none can help patients regain the self-controlled
bladder and bowel function. Furthermore, treatments like
catheterization, sacral anterior root stimulation, colostomy,
and enema will likely cause additional pain and other side
effects to patients. Therefore, an effective and safe treatment
with few side-effects is warranted for the treatment of bladder
and bowel dysfunction in patients with traumatic SCI.
Acupuncture is a therapy that is commonly utilized by the
Chinese people for the management of bowel and bladder
dysfunction. Documentation of acupuncture use for bowel
and bladder symptoms dates back to thousands of years ago
in the ancient medical monograph Huang Di Nei Jin (Yellow
Emperor’s Inner Canon). Propositions of therapeutic effects
of acupuncture in neurogenic bowel and bladder dysfunc-
tions are supported by modern research studies. Compared
with urinary catheterization or use of medications, Cheng
et al. [7] found that electroacupuncture (EA) could help
acute SCI patients with neurogenic bladder achieve balanced
(continent, catheter-free) bladder function, and Wong et al.
[8] demonstrated that EA at SI3 and BL62 in conjugationwith
auricular acupoints promoted bladder function recovery in
patientswith acute SCI. In addition,Wong et al. [8] also found
that EA could decrease the needwith bowel care and episodes
of fecal incontinence due to SCI. Similarly, manual acupunc-
ture was found to induce resolution of urinary incontinence
in 15% of patients with SCI-induced detrusor hyperreflexia
[9]. In addition, the results of our previous case series study
[10] and the study by Honjo et al. [9] indicate that EA could
improve voiding abilities in patients with SCI. Among the
aforementioned research studies, effects of EA on both bowel
and bladder functions were only reported in the study by
Wong et al. [8]. Nonetheless, due to that the main purpose
was patients’ general functional recovery after SCI, Wong et
al. [8] did not provide sufficient information (such baseline
values of patients’ voiding abilities) regarding patients’ bowel
and bladder function. As quality of these acupuncture studies
is of dispute, conclusive evidence regarding acupuncture
effects in patients with simultaneous neurogenic bowel and
bladder dysfunction after traumatic SCI is still lacking [11].
Consequently, in the present study, we aimed to explore the
effects of EA for chronic bowel and bladder dysfunction after
traumatic SCI.
2. Materials and Methods
2.1. Study Design. This was a prospective consecutive case
series study performed at the Acupuncture Department
of Guang An Men Hospital, China Academy of Chinese
Medical Sciences. The hospital ethics committee approved
this treatment protocol, and all patients signed informed
consent before study participation. Acupuncture procedures
were implemented by senior acupuncturists at the depart-
ment with more than 20 years’ clinical experiences. Data
management and analysis were performed by graduates who
were blinded to the treatment procedures.
2.2. Participants. For inclusion, the participants had to fulfill
the following criteria: (1) simultaneous bladder and bowel
dysfunctions caused by traumatic SCI of or above Level L1; (2)
no history of sphincter injury or surgery of the urinary tract,
gastrointestinal tract, or anus; (3) SCI history for no less than
six months and onset of bowel and bladder symptoms after
SCI; (4) theymust be at least 18 years old; (5) cardiac, hepatic,
and renal functions as well as coagulative functions are
normal or near normal; (6) no cognitive or mental disorders.
2.3. Acupuncture Protocol. Huatuo brand needles (size
0.45mm × 125mm and 0.30mm × 75mm, manufactured by
SuzhouMedical Appliance, Suzhou, Jiangsu, China) together
with GB6805-2 Electro-Acu Stimulators (Medical Supply
& Equipment Co., Ltd., Shanghai, China) were used. The
parameters of electric stimulation were set as the follows:
continuous wave with electric current frequency of 20Hz
and intensity between 3 and 10mA according to patients’
tolerance. Based on the clinical experiences and anatomical
knowledge (direct stimulation of S2-S3) of the acupunctur-
ists, bilateral BL32, BL33, and BL35 were used.
Acupoints were selected and localized according to the
WHO Standardized Acupuncture Points Location [12]. Nee-
dles of the size of 0.30mm × 75mm were inserted into
bilateral BL35 verticallywith a depth of 45–75mm; 0.45mm×
125mm size needles were inserted inwardly and downwardly
into bilateral BL32 and BL33 (S2 and S3 foramina) at an angle
of 20–30∘ with a depth of 80–90mm. Paired alligator clips
with negative and positive electrodes of the EA apparatus
were attached to the needle holders at each pair of the same
acupoints on each side during treatment. The positive elec-
trodes were attached on the left, and the negative electrodes
were attached on the right. Each EA treatment lasted for 50
minutes. All patients received EA treatment once a day, five
times aweek for the first fourweeks, and once every other day,
three times a week for the following four weeks. The patients
were then followed up for 6 months.
2.4. Outcome Measurement. Bladder functions including
postvoid residual urine volume (RUV), weekly urinary
incontinence frequency, and additional conservative inter-
ventions (if any) were measured and documented at baseline,
after treatment, and during followup. With reference to the
International Lower Urinary Tract Function Basic Spinal
Cord Injury Data Set [13], normal voiding in the present
study is defined as voluntary initiation ofmicturition without
reflex stimulation or compression of the bladder. Based on
patients’ voiding abilities during the past 24 hours, they were
divided into three groups after treatment: patients who had
normal voiding all the time were categorized into Group A;
patients with normal voiding frequency no less than half of all
micturition behaviors were categorized into Group B; all the
remaining patients who require assistive urination help with
a frequency for higher than half of all micturition behaviors
were categorized into Group C.
With reference to the International Bowel Function Basic
Spinal Cord Injury Data Set [14], patients’ bowel movements
were divided into normal, partially normal, and complete
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constipation. In the present study, normal bowel movement
is defined as self-initiated bowelmovements without any help
of supplementarymethods during the past 48 hours; partially
normal bowel movement is defined as more than half of the
times that patient have self-initiated bowel movements with
occasional supplementary defecation method use during the
past 48 hours; complete constipation is defined as more
than half of the times that patient require supplementary
defecation method use for bowel movements during the past
48 hours. Postvoid RUV was measured using a cylinder via
self-urethral catheterization after urination. The frequencies
of normal voiding and urinary incontinence, postvoid RUV,
and bowel movement conditions, as well a supplementary
urination and defecation methods were recorded by our
research staff in a bladder and bowel diary each time during
patients’ visit.
2.5. Safety Measurement. Adverse events which may include
hematoma, fainting, and unbearable pain and others were
documented during study.
2.6. Statistical Analysis. Statistical analysis was performed
with the SPSS software package (Version 17.0) for Windows
XP. Quantitative data of postvoid RUV and weekly urinary
incontinence frequency were expressed with mean ± stan-
dard deviations (SD). Paired samples t-test was used to mea-
sure the difference among values at baseline, after treatment,
and during followup.A significance level of𝑃 < 0.05 and two-
tailed tests were used for all analyses.
3. Results
As presented in Figure 1, fromDecember 12, 2007, to October
31, 2011, a total of 69 patients with SCI visited the Outpatient
Department of Acupuncture at Guang An Men Hospital.
Among these patients, 25 had bladder and bowel dysfunc-
tions; however, 11 of them were excluded from the present
study for the following reasons: six patients had SCI injury
less than six months ago; three patients were younger than 18
years old; two patients received EA treatment less than 5 times
and dropped out during treatment. Consequently, 14 patients
were included in the final analysis.
Of these 14 patients, nine were male and five were female;
eight had motor vehicle accident, five were injured from
falling, and one was injured by gun shot. The mean age of
these participants was 34 years old with a range from 21 to
57 years old. The mean disease course was 16.3 months with
a range from six months to nine years. In these 14 patients,
two patients’ injuries were at the cervical level, two at the
upper thoracic level, four at the lower thoracic level, and six at
the lumbar level. According to American Spinal Cord Injury
Association (ASIA) Impairment Scale (AIS) classification
[15], impairments of the included patients were classified as
follows: five had Grade A (complete) impairment, six had
Grade B (sensory incomplete) impairment, and three had





∙ Did not have simultaneous bladder
and bowel dysfunction
(n = 44)
∙ History less than 6 months
(n = 6)
∙ Younger than 18 years old
(n = 3)
∙ Received EA treatment less than 5
times and dropped out
(n = 2)
Patients accepted acupuncture treatment
(n = 14)
∙ Gender: female (n = 5), male (n = 9)
Falling injury (n = 5)
∙ Causes: motor vehicle accident (n = 8)
Gunshot injury (n = 1)
∙ Age: 21∼57 years old
∙ History: 6 months ∼9 years
Figure 1: Flow chart of study participation.
3.1. Assessments of Bladder Function. Before treatment, all 14
patients had no normal voiding ability and required assisted
therapies (intermittent catheterization or abdominal push) to
empty the bladder. After eight-week treatment, four (4/14,
28.57%) patients resumed normal voiding (Group A); six
(6/14, 42.86%) resumed normal voiding for no less than half
of all micturition behaviors (Group B); four (4/14, 28.57%)
required assistive urination therapies for higher than half
of all micturition behaviors (Group C). In the six patients
of Group B, three patients required bladder emptying via
abdominal push, two required intermittent catheterization,
and one required both. Similar results were found during
followup (Table 1).
Mean postvoid RUV for these 14 patients decreased by
190.29 ± 101.87mL after treatment, from 262.43 ± 131.50mL
at baseline to 72.14 ± 83.59mL (𝑃 = 0.000). Compared with
baseline, the mean postvoid RUV was decreased by 198.86
± 112.18mL during followup, from 262.43 ± 131.50mL at
baseline to 63.57 ± 75.71mL (𝑃 = 0.000). Compared with
baseline, the mean postvoid RUV of patients was decreased
by 190 ± 108.62mL after eight-week treatment and by 192 ±
107.82mL during followup in Group A; the decreases were
177.33 ± 112.01mL after treatment and 179.00 ± 110.70mL
during followup in Group B, and 202.50 ± 118.43mL after
treatment and 220.00 ± 163.10mL during followup in Group
C (see Figure 2 and Table 2).
Of these 14 patients, seven patients (7/14, 50.00%) had
various degrees of urinary incontinence. Five out of these
seven patients were diagnosed as detrusor hyperreflexia












Figure 2: Histogram of mean postvoid RUV. Group A refers to
patients who had normal voiding all the time; Group B refers
to patients with normal voiding frequency no less than half of
all micturition; Group C refers to patients who require assistive
urination help with a frequency higher than half of all micturition.
through urodynamic study (UDS) before treatment; the re-
maining two patients lacked relevant examination. After
treatment, the weekly urinary incontinence frequency for
these seven patients reduced from 79.14 ± 64.80 times/week
at baseline to 32.00 ± 20.94 times/week (𝑃 = 0.036);
during followup, the weekly urinary incontinence frequency
reduced to 29.28 ± 22.71 times/week (𝑃 = 0.025). Among
the remaining seven patients who had urinary retention
before treatment, four patients were diagnosed as detrusor
areflexia through UDS, and the other three patients did not
provide UDS information. During treatment, five (all four
patientswith detrusor areflexia and onewith insufficientUDS
information) out of these seven patients with urinary reten-
tion developed urinary incontinence. Two patients developed
urinary incontinence during the 2nd week; however, the
urinary incontinence symptoms were completely gone by the
end of the 4th week. The remaining three patients developed
urinary incontinence during the 8th week with a frequency
of three times per week, 10 times per week, and five times per
week, respectively; however, two out of these three had no
incontinence during followup; the remaining one continued
to present with urinary incontinence which was 5 times per
week during followup.
3.2. Assessment of Bowel Function. Before treatment, all
14 patients had constipation and required supplementary
methods for defecation, and thus their symptoms were
considered as complete constipation. After treatment, four
(4/14, 28.57%) resumed normal bowel movements; five (5/14,
35.71%) regained partially normal bowel movements and
reduced the dependence on supplementary defecation meth-
ods; five (5/14, 35.71%) had no change. In the five patients who
regained partially normal bowel movements, one resumed
the desire to defecate, one resumed anal reflex, and three
regained the soft and smooth stool which was made of nuts-
like hard lumps before. The effects of EA were maintained
during followup (Table 1).
3.3. Adverse Effects. No adverse effects were found. Five
patients with residual sensory functions reported pain,
sourness, numbness, and/or distension upon acupuncture
procedures, which were well tolerated during treatment
and disappeared after needle removal. Based on traditional
Chinese medicine theories, these sensations are likely to be
categorized into theDeQi sensations and are thus considered
normal during acupuncture treatment [16].
4. Discussion
4.1. EA and Function Recovery in SCI Patients. Under phys-
iological conditions, neurons are considered as permanent
cells which remain in the G0 phase and lack proliferation.
With spinal cord injury, sprouting and regeneration of the
CNS tracts depend on the functions of glia cells due to the
poor regenerative capacity of axons [17]. The development
of a glial scar and the accumulation of extracellular matrix
(ECM) proteoglycans generate an impermeable barrier that
further hinders axons from regenerating across the site of
injury [18, 19]. Thus, neurological dysfunctions caused by
SCI are generally considered extremely difficult to recover
[11]. Patients with SCI who have no perianal pinprick sen-
sation at initial evaluation never regain volitional voiding
and bowel function recovery following SCI is not favorable
[20]. Therefore, therapies that enhance more natural patient
control of voiding anddefecation are appealing. In the present
study, adult patients with a history of chronic neurogenic
bowel and bladder symptoms were included. Improvements
in bowel and bladder functions in these patients are more
likely to be related to the therapeutic effects of EA rather than
spontaneous recovery.
4.2. Bowel and Bladder Functions with EA. Improvements
of bowel and bladder functions will reinforce patients’ con-
fidence in recovery, encourage patient’s social interaction,
and increase the quality of life and thus greatly decrease
the incidence of SCI-associated complications and the devel-
opment of other comorbidities [11]. Recently, sacral neuro-
modulation which employs implants of electric stimulator
in the pelvic region and surgical reinnervation with nerve
anastomosis were found effective in the treatment of bowel
and bladder dysfunctions caused by TSCI [21–23]. However,
these interventions require surgical procedures which may
be only applicable to a limited number of patients and may
be accompanied with unfavorable side effects [5]. EA at
S2-3 provides a combinational stimulation of acupuncture
and electric therapy; therefore, EA therapy in the present
study can be considered as minimal invasive type of sacral
neuromodulation which has minimal side effects.
Results of the present study indicate that EA at S2-3 and
perianal region could improve patients’ voiding abilities. The
results were consistent with our previous findings in which 10
out of 15 patients with cauda equina injury resumed voiding









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































8 Evidence-Based Complementary and Alternative Medicine
abilities and were urinary catheter-free after a similar EA
treatment protocol [10]. Honjo et al. [9] found that EA at
S2 was found to be effective in improving bladder control
decreasing incontinence frequencies in patients with detru-
sor hyperreflexia. The present study demonstrated a similar
response of EA via decreasing patients’ incontinence fre-
quencies. In the present study, detrusor hyperreflexia in nine
patients (five patients with previous detrusor hyperreflexia
and four patients with transient detrusor hyperreflexia) was
successfully treated by EA and had no urinary incontinence
at the end of treatment. Furthermore, Wong et al. [8] found
that EA could decrease incontinence frequencies or assistance
for bowel care in patients with SCI; the results of the present
study indicate that EA could increase patients’ abilities to
self-initiate bowel movements and decrease the need of
supplementary defection methods. Thus, the results of the
present study add further credence to the therapeutic effects
of EA on neurogenic bowel.
Bladder functions can also be reflected by postvoid RUV.
In the present study, postvoid RUV was measured using a
cylinder via self-urethral catheterization after full urination.
This technique theoretically provides reliable information
regarding residue urine volume and thus the first impression
of patients’ voiding function [24]. In the present study, EA
was found to significantly decrease postvoid RUV both after
treatment and during followup. These results echo with
our previous findings in patients with cauda equina injury
patients [10]. The decrease in postvoid RUV reflects the
improvement of voiding ability with EA in patients with
neurogenic bladder. In addition, findings of heaven amount
of postvoid RUV in patients with urinary incontinence or
detrusor hyperreflexia in the present study indicate that
involuntary contraction in urinary incontinence is ineffective
which concurs with other urinary incontinence studies [25,
26].
4.3. Possible Therapeutic Mechanism of EA in Bowel and
Bladder Dysfunctions. In conjuncture with evidence from
the aforementioned research studies, we hypothesize that EA
sacral nerve stimulation could modulate urinary functions
in patients with SCI. Pelvic splanchnic nerves do not only
provide parasympathetic innervations to the detrusor mus-
cle responsible for involuntary bladder emptying, but also
parasympathetic innervations to the sigmoid colon and rec-
tum responsible for involuntary bowel movements. Somatic
components of the pudendal nerve directly innervate the
external urethral sphincter and the external anal sphincter
via its branches of inferior anal nerves; normal functions of
these sphincters serve as the foundation for normal bowel
and bladder control. Both the pelvic splanchnic nerves and
pudendal nerve arise from S2–S4; therefore, EA at S2-3
provides direct electric and mechanical stimulation to these
nerves. Nonetheless, EA stimulation at S2-3 is nonselective
which indicates two extremely opposite conditions. This
could at least partially contribute to the interesting opposite
phenomena (effects on neurogenic urinary retention and
urinary incontinence) discovered with EA treatment at S2-
3 [9, 10]. To better utilize this minimal invasive direct nerve
stimulation, more studies are warranted to develop selective
EA treatment on the parasympathetic nerves or the pudendal
nerve.
4.4. Limitations. Nonetheless, the present study is a case
series study with a relative small sample size which indicates
that results of the present study may not well represent the
general response of patients with chronic bowel and bladder
dysfunction caused by SCI. For example, in the present
study, standard deviations of some quantitative measure-
ments (such as postvoid RUV and the change of weekly
urinary incontinence frequency after treatment) were bigger
than its corresponding mean which indicates relative wide
dispersions of values in the small sample and is unfavorable
for the statistical analyses. Assessments of acupuncture effects
in the present study mainly depend on patients’ reports
whichmay be interfered with recall bias and patients’ believes
and emotional status upon visits. To objectively evaluate
EA effects on neurogenic bowel and bladder dysfunction,
we may need to incorporate urodynamic measurements in
future studies. Furthermore, assessment of bowel functions is
limited to patient-reported bowel movement frequencies and
supplementary defecation methods, information like average
time required for defecation, frequency of defecation, and
frequency of fecal incontinence is lacking.
5. Conclusion
In patients with chronic bowel and bladder dysfunction after
SCI, EA may provide a valuable alternative tool in improving
patients’ self-controlled bowel and bladder functions.
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